Member Info for PhatStyle4321

Knock off the value of the shares it holds in Skinbiotherapeutics and that is c£30 million. I happen to think that this will be seen as a very low multiple of profits in 2022 which will be the second year of profits. Moreover I regard it as perfectly possible that Skinbiotherapeutics shares could double or treble from here (40p) with Winclove and Croda both set to deliver revenues from this year.

Looks like everyone is very bullish about our share, at least double or triple from here. I wonder how many problem/investors will be kicking themselves once we are at £1 a share it will be very interesting.

I agree Bel, depending on results and if they are as good as the pictures suggest, then articles and newspaper will be likely reporting on the huge improvements this probiotic can offer. I know that people who suffer with psoriasis tend to know other sufferers and I believe word of mouth alone would increase the exposure of this probiotic. I believe, if successful this one product could shift us from £60m to £1 billion.

As the beginning of April approaches, investors will start taking positions I am guessing at 60p before results are announced? Anyone else got any other predictions, closest one will win a very nice prize

News on any other fronts could drop here anytime, right now it is our psoriasis study that everyone has their eye on, and from the discussion on the released images, it is going very well. This company can’t just get better, easily a double from here

Totally agree with you Ted, Seneca looks to be selling down more which is fair enough as they are probably sitting on a huge paper profit at the moment. The product seems to be working miracles, let’s see if it lasts. Nearly another week down until the long awaited results

I was lucky enough to see the images before they went down and wow what an improvement in just a week. I also hear other sources are reporting positive results. It is still early days however this probiotic looks to be a real game changer and the potential here if it actually works according to the images will be astonishing. I would expect with this product alone to increase at least 8 fold here, it will also put us in good stead ahead of the Croda beauty parade. I also believe more IP rights are in process too. I won’t be surprised if we are brought out before then. £3 a share would do me nicely

This will surpass all time highs very quickly ITM are positioned superior for the green blast off, brace for tomorrow’s budget

Think we could easily reach back to £7 especially after Wednesday budget and big push for green energy

https://www.google.co.uk/amp/s/amp.ft.com/content/09587e4f-16c3-41bb-8df8-bcb8100fda94

Only matter of time before all stocks including ITM hit all time highs

Volume is huge today and potential even bigger

This is my prediction!

Sorry to those that hold

If the trial is a success I wonder what the price will jump to? I am thinking £1. With the trial having started some people maybe noticing results already. What an opportunity to load up before April, let’s all not forget the Croda deal aswell. We have to say a huge well done to the CEO and the team for getting us here

There will be a rush of this morning I believe right back over 70p today I believe, no reason for this crazy drop, I am buying more this am

On no news this has been taken down, probably a big holder just exiting, will see it back up to 70p just like it did last time, I will be making a sizable top up this morning

Looks like a fund or someone big is buying currently, let’s see if we can get to all time Highs!!

With the trial started and everything going according to plan we will start seeing positions being built here, 50p this week would be lovely, £1 by June is my prediction, remember PhatStyle said it first

Seems like the majority think SKIN is the better investment than OPTI as harsh as it sounds. Covid has affected many businesses but SKIN seems to be immune to this. I personally think Skin is a lot better than OPTI

Aquae, did you read the Opti update ? It reads clearly that OPTI are more excited about SKINBIO’s developments than their own. They most certainly know the potential more than the average investor and now that it plays such a vital role in OPTI’s valuations I am sure they won’t be selling anything until the price is much higher, over £1. Why would they do a dividend as that would be a short gain at a sacrifice of the potential they could receive in the years to come. It also seems if everything goes to plan SKIN’s could be paying OPTI a dividend and yet another source of revenue. It seems that you have a share in OPTI, and good luck to you if you do but I just don’t see the two compare. Skin has so much more potential and growth prospects than OPTI.

If you read the Opti RNS, it states that the OPTI board agrees for the long term potential for SKIN and a lot of emphasise is put on SKIN which suggest to me they are in this for the long haul. Also in the current climate SKIN has been the saving grace for OPTI, and will continue to do so. OPTI has many ways to raise cash if they need it and selling SKIN will be the worst option and will destroy the only shining value they have in all of their investments